GI Cell (지아이셀)

Gi cell (지아이셀) email format

Verified email-pattern data for Gi Cell (지아이셀) is currently limited. You can still use the company insights and contact sections below.
GI Cell was founded by Dr. Myoung Ho Jang, an intestinal immunologist, in Oct 2018. 82 employees (as of Mar 2021) are working in our company and around 40% (15/41) of R&D members are Ph.D. GI Cell has innovative platform technology for screening and optimizing ancillary proteins for target immune cells. Several cell therapy pipelines for treatment of cancer, inflammatory disorders are in the pre-clinical development stages. GI Cell also develop multi-valent sub-unit vaccines for COVID-19 based on experience in ancillary protein engineering and profound understanding in immunology. 1) Immune Cell pure Expander : Platform technology that enables screening and optimizing ancillary proteins to maximize expansion capacity, purity, and functional activity of target immune cells during cultivation. With this optimized ancillary protein, we epigenetically improve NK cell, CD8 T cell, Treg cell to have high potency and targeting efficiency without cancerous feeder cell (in case of NK cell) and genetic engineering. For more information, please visit our websites or contact by e-mail (contact@gi-cell.com).

Company Details

Employees
31
Founded
-
Address
경기도 성남시 중원구 갈마치로288번길 14, 비동 1553호(상대원동, 성남 Sk V1 Tower), 성남 Skv1 Tower,korea, Republic Of
Industry
Pharmaceutical Manufacturing
Keywords
Seongnam-si.
HQ
성남시, 경기도
Looking for a particular GI Cell (지아이셀) employee's phone or email?

Gi Cell (지아이셀) Questions

Top GI Cell (지아이셀) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant